PubMed Health⌕ Search

Biomedical subjects

H J Becker

Publications and source records attributed to H J Becker.

At least 19 recordsLinked to original sources

[Recommendations for statin therapy in the elderly].

Elderly patients are significantly less likely to receive statins than younger patients possibly because of doubts regarding compliance or concerns regarding the increased likelihood of adverse events and drug interactions. Poor compliance can be expected especially in patients suffering from dementia or depression as well as those whose stage of cardiovascular disease exhibits few symptoms. On the other hand, the clinical significance of CHD events is high in the elderly, and 80% of coronary deaths occur in patients aged over 65 years. The average statistical life expectancy of elderly and old patients is often underestimated. The HPS and PROSPER studies showed that statins reduce mortality and morbidity even in very elderly individuals with a high global cardiovascular risk and/or CAD. Patients up to the age of 79 years should be treated according to the same guidelines as younger patients. Statin therapy should only be considered for patients aged 80 years and older who are at a very high risk for cardiovascular events.

Aged↗

[Biodegradable miniplates (lactosorb) in cranio-osteoplasty--experimental results with the rapidly maturing, juvenile minipig].

As a passive intracranial transmission (PIT- effect) has been described for metallic osteosyntheses materials in the infant growing skull. Thereby the use of resorbable plates and screws might be an alernative fixation device in infant craniofacial surgery. For evaluating the biological behaviour, craniotomies were performed in the frontoorbital region of four infant minipigs, six weeks of age and 6.1 kg of weight. After turning and orthotopical repositioning the full thickness bone graft were fixed with resorbable plates and screws made of LactoSorb on the left side after epiperiosteal, on the right side after subperiosteal preparation. The animals were sacrificed after 3, 6, 9 and 18 months. Histologically, a PIT- effect was detected similar to metallic microplates and screws being significant diminished after epiperiosteal preparation and plate positioning. The biodegradation was not affected by intraosseous translocation. Even in case of intrasinuidal transmission no inflammatory reactions werde observed. No contraindications for the clinical use of this specific PLLA-PGA copolymer could be found when implanted in the rapidly growing craniofacial bone surfaces.

Animals↗

The resorbable miniplate system Lactosorb in a growing cranio-osteoplasty animal model.

In the surgical treatment of craniosynostosis and craniofacial dysostosis in the growing child, passive intraosseous translocation (PIT effect) with intracranial displacement of metal plates and screws may be a problem. In an animal experiment, a possible PIT effect using resorbable PLA/PGA miniplates (Lactosorb, W. Lorenz, FL, USA) following cranio-osteoplasty were investigated in four young Göttingen minipigs. In addition to the mechanical properties, the processes of degradation and of sub- vs supraperiosteal application of the miniplates were evaluated. During degradation the resorbable PLA/PGA miniplates performed like metal plates as they also displayed passive intraosseous translocation in the growing animal model. However, in the experimental PLA/PGA miniplating the internal calvarial bone was not affected. Degradation took 12-18 months and was not delayed by bony incorporation. Mechanical properties proved to be sufficient in craniofacial surgery. Supraperiosteal plating delayed the PIT effect during the first 3 months after surgery. In the growing skull resorbable plates seem to be a promising therapeutic approach. However, prior to a general recommendation results of long-term clinical studies have to be evaluated.

Absorbable Implants↗

Feasibility and sensing thresholds of temporary single-lead VDD pacing in intensive care.

Long-term pacemaker treatment of patients with a high-degree atrioventricular (AV) block routinely uses AV synchronous pacing because of its hemodynamic advantages compared with VVI pacing. In cases of temporary pacing, however, the limitations inherent in attempting to reliably position a temporary atrial lead generally influences the use of VVI pacing. We therefore tested the use of temporary single-lead VDD pacing, making AV pacing possible with only 1 lead, in 22 patients requiring temporary pacing due to a high-degree AV block. AV synchronous stimulation was achieved in all patients using a quadripolar lead with an atrial dipole with the atrial rings spaced 30 mm apart. During follow-up (14.1 +/- 12.5 hours) intermittent undersensing was detected in 4 of the 22 patients. We initially evaluated the atrial sensing threshold by decreasing the pacemaker device sensitivity stepwise in all patients (1.54 +/- 1.08 mV; n = 22). In 15 patients an intra-atrial electrocardiogram was recorded. During the breathing cycle, the maximum P-wave amplitude was significantly different from the minimum P-wave amplitude (2.19 +/- 1.00 mV vs 1.25 +/- 0.65 mV, p < 0.005). The atrial signal detected by the single lead was further analyzed in 10 of 15 patients using various filters. A mean signal loss of 45% was observed, increasing the lower bandpass frequency from 0.1 to 40 Hz (1.73 +/- 0.71 mV vs 0.92 +/- 0.51 mV, p < 0.02). Lowering the upper filter range from 1,000 Hz down to 100 Hz did not significantly influence the atrial signal (1.73 +/- 0.71 mV vs 1.61 +/- 0.75 mV, NS). Single-lead VDD pacing, even on a temporary basis, is a reliable means of achieving AV synchronous pacing. Due to the floating atrial dipole, the system is characterized by a high degree of variability in the atrial signal with intermittent lower values. A significant signal loss must be expected when a lower bandpass frequency of 40 Hz is used.

Aged↗

[Significance of periosteum in profile and contour improving osteotomies of the growing skull. Animal experiment studies with the juvenile minipig].

Passive intracranial translocation of plates and screws (PIT effect), which has been described in the literature, is one of the undesirable outcomes in infant craniofacial surgery. Therefore, we investigated the hypothesis of whether epiperiosteal placement of plates and screws causes the periosteum to act as a "limiting membrane", possibly preventing or delaying passive intracranial translocation of hardware. In two different experimental models of the fast-growing skull of juvenile minipigs (16 or 7 weeks old) on one side of the skull a typical, standard galeaperiosteal flap was raised. On the contralateral side, the periosteum was left attached to the bone and after performing the osteotomies, plates and screws were placed on top of the periosteum. This technique showed that the periosteum acts as a "limiting membrane" and prevents early covering of the hardware by appositional bone growth. Thus, plates and screws could easily be identified if removal was intended. In contrast to this, on the subperiosteal side (conventional technique of raising a galeaperiosteal flap), plates and screws were already completely covered by appositional bone formation 8 weeks postoperatively. The posterior bone gaps that resulted from fronto-orbital advancements showed significant delay in reossification when the epiperiosteal technique was used. This may be advantageous for the growth of the skull following fronto-orbital advancements. In contrast, the posterior bone gap showed early reossification when the standard subperiosteal technique was used. Thus, in infant craniofacial surgery, the epiperiosteal technique and placing the plates and screws on top of periosteum seem to have some advantages compared to the standard subperiosteal technique.

Age Factors↗

Effect of neurotensin on pancreatic growth and pancreatic polyamine metabolism in rats.

The neuropeptide neurotensin is known to play a role in the regulation of exocrine pancreatic secretion, but actually there are conflicting results as to whether or not neurotensin exerts a trophic response on the pancreas and there are no data concerning its effect on pancreatic polyamine metabolism. In the present study, acute and long-term effects of various intraperitoneal dosages of neurotensin that resulted in mildly supraphysiological and even unphysiological high plasma concentrations of neurotensin were studied. Furthermore, neurotensin was simultaneously administered with cholecystokinin (1 microgram CCK-8/kg body wt ip every 8 h) for five days. The administration of neurotensin resulted in an acute significant decrease of pancreatic amylase and trypsinogen concentrations (p < 0.001), which indirectly confirms the potent effect of neurotensin on pancreatic exocrine secretion. In contrast to that, neither during the short-term study (100 micrograms neurotensin/kg body wt ip every 8 h for 2, 4, 6, 8, 16, and 24 h) nor during the long-term study (1 microgram, 100 micrograms, or 200 micrograms neurotensin/kg body wt ip three or eight times daily for 10 d) did neurotensin administration result in any increase of the various parameters of pancreatic growth and polyamine metabolism. Simultaneous administration of neurotensin and CCK failed to alter or further increase the known stimulatory effect of CCK on pancreatic polyamine metabolism and pancreatic growth after 5 d of treatment. These data indicate that neither alone nor in combination with cholecystokinin did various dosages of neurotensin exert any significant stimulation on pancreatic growth or the parameters of pancreatic polyamine metabolism.

Animals↗

[Atrial sensing by a new VDD pacemaker].

VDD stimulation is an alternative to DDD pacing due to the possibility of p-wave synchronous ventricular pacing without the need of an atrial lead. Mainly, the reliability of the system depends on the atrial sensing. In 22 patients the intraoperative atrial amplitude and, postoperatively, the atrial sensing threshold were measured. Furthermore, the stability of the atrial sensing threshold during follow-up was proven. The mean atrial amplitude was intraoperative by 2.4 +/- 1.2 (1.0-6.8) mV. The measurement of the atrial sensing threshold in the first 5 postoperative days showed a mean value of 1.02 +/- 0.49 (0.3-1.6) mV. The measurements of the mean atrial sensing threshold after 30, 90, and 180 days showed no statistical differences. Intraindividual variance was shown in 17/20 patients (0.55 +/- 0,42; 0.15-1.05 mV). Seventeen of the 22 patients were programmed with an atrial sensing threshold of 0.3 mV. In five patients the atrial sensing threshold was programmed at less than 0.3 mV in order to reach a twofold atrial sensitivity. Despite a programmed atrial sensitivity of 0.1 mV and isometric conditions no atrial oversensing occurred. The postoperative atrial sensing thresholds of the VDD system investigated were significantly lower than the intraoperatively measured atrial amplitudes. The mean atrial sensing threshold did not change during the follow-up period. The variation which did occur was within individual variation at different return visits.

Aged↗

Echocardiographic visualization of anomalous left main coronary arteries originating from the right sinus of Valsalva.

We report on two patients in whom the anomalous left main coronary artery arising from the right sinus of Valsalva with a septal course could be visualized by transthoracic echocardiography. It appeared as a small echo-free space, anterior to the aorta in the short parasternal axis. If the left main coronary artery arises anomalously from the right sinus of Valsalva, it can take four different courses until it branches into the left anterior descending and the circumflex coronary artery. The course between aorta and pulmonary trunk can be differentiated into an interarterial and a septal course using angiographic criteria. The interarterial course is a potentially life-threatening anomaly due to a high rate of myocardial infarction and sudden cardiac death. Echocardiography alone seems not to be able to distinguish between the potentially life-threatening interarterial and the benign septal course, as in our patients.

Coronary Angiography↗

[Cor triatriatum sinistrum and atrial septal defect].

The cor triatriatum sinistrum is a rare congenital malformation. Frequently, the patients become symptomatic in infancy with clinical signs of severe congestive heart failure. We report on an adult patient with only mild symptoms with cor triatriatum sinistrum and atrial septal defect. The embryological basis of the disorder and the hemodynamic conditions which permitted this patient to remain symptom free for a long period are discussed.

Atrial Function, Left↗

High rate of late dislodgements of an active fixation atrial lead.

Between May 1985 and May 1991 we implanted 115 DFH-leads as unipolar atrial leads. The active fixation mechanism of this electrode consists of two sickle-shaped anchoring hooks which are placed at a distance of 0.9 mm parallel to the distal flat end of the electrode. All leads were affixed to the free wall of the right atrium. One hundred eight leads (93.9%) were implanted for dual chamber pacing and seven leads (6.1%) for single chamber atrial pacing. Parameters measured at implantation were (mean values): stimulation threshold 1.06 +/- 0.42 V at 0.5 msec pulse width, P wave amplitude 5.12 +/- 2.04 mV, and lead impedance 560 +/- 76.1 Ohms. Within the first week after implantation, three early dislodgements occurred (2.6%). The follow-up period averaged 30.4 +/- 16.2 months (range 2-76 months). During this time, 14 late macrodislodgements (12.2%) occurred after a mean period of 18.4 months (range 2-59 months). All of them required reoperation. The active fixation mechanism of the DFH-lead appears to be unreliable, if implanted in the free wall of the right atrium for dual chamber pacing.

Adult↗

A case of hidden receptacle-adapter incompatibility.

Connection of a universal VS-1 adapter to a VS-1 receptacle resulted in intermittent loss of pacing and of sensing in a pacemaker dependent patient. This was caused by the use of an adapter that only provides stable electric contact if the adapter pin is deformed by the set screw. Since we had implanted a pulse generator with a "side-lock" connector without screws, only a loose connection was achieved. The manufacturers should provide information on such hidden incompatibilities.

Adult↗

[Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease].

The dose-effect relation and duration of action of 10 mg, 20 mg, 40 mg, and 80 mg ridazolol on ischemic ST-segment depression in exercise-ECG were determined in a randomized, double-blind, acute, cross-over study of 15 patients with confirmed coronary artery disease and reproducible ST-segment depression. Maximal reduction of ST-segment depression in comparison to placebo during constant exercise was 0.16 vs. 0.25 mm (n.s.) after 10 mg, 0.09 vs. 0.25 mm (p less than 0.01) after 20 mg, 0.11 vs. 0.25 mm (p less than 0.01) after 40 mg, and 0.07 vs. 0.25 mm (p less than 0.01) after 80 mg ridazolol. A remarkable reduction of ST-segment depression under placebo was seen in the third and fifth hours after application. Systolic blood pressure under exercise was reduced significantly after 80 mg ridazolol (145 vs. 176 mm Hg; (p less than 0.05) over a period of 5 h. Heart-rate was reduced significantly after 80 mg ridazolol (102 vs. 131/min; p less than 0.05) for 5 h. Rate-pressure product after 20 mg (174 vs. 234 mm Hg/min; p less than 0.01), 40 mg (169 vs. 234 mm Hg/min; p less than 0.01), and 80 mg (153 vs. 234 mm Hg/min; p less than 0.01) ridazolol was reduced significantly over 3 to 5 h. 20, 40 and 80 mg ridazolol show a good antianginal and antihypertensive efficacy. Blood pressure and heart-rate under exercise were significantly reduced over 5 h. In contrast, improvement of ST-segment depression only lasted 1 h. Ridazolol was well tolerated.

Adrenergic beta-Antagonists↗

Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects.

In 10 healthy male subjects the pharmacokinetics and haemodynamic effects of sustained-release isosorbide-5-mononitrate 60 mg (IS-5-MN) were studied after oral administration at two different times in the day (08.00 h and 20.00 h). Effects on blood pressure and heart rate after 3 min standing upright were measured in relation to the individual circadian control values. The pharmacokinetic parameters (Cmax, tmax, AUC, t 1/2) did not differ after morning and after evening dosing, tmax being 5.2 h and 4.9 h, respectively. In contrast, the cardiovascular effects of IS-5-MN were clearly circadian phase-dependent. The maximum decrease in blood pressure decrease and increase in heart rate occurred significantly earlier after the evening (BPsys 2.8 h; BPdia 2.9 h; HR 3.8 h) than after the morning dose (BPsys 5.0 h; BPdia 6.0 h; HR 5.2 h). Thus, the peak haemodynamic effects coincided with the peak drug concentration after the morning dose, whereas the peak effect was in advance of the peak drug concentration after the evening dose of IS-5-MN. The data provide evidence of circadian phase-dependency in the dose-response relationship of oral IS-5-MN.

Administration, Oral↗

Clinical chronopharmacology of oral nitrates.

The clinical-chronopharmacological investigations with oral nitrates (ISDN, IS-5-MN) demonstrate that the drugs' pharmacokinetics and/or hemodynamic effects are circadian phase-dependent. For both an immediate-release and a sustained-release preparation of IS-5-MN peak drug concentrations coincided with peak drug effects after morning but not after evening drug application. Results indicate a circadian phase-dependency in the dose-response relationship of oral nitrates.

Administration, Oral↗

[Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].

The dose-effect relation and duration of action of 2 mg, 4 mg and 6 mg molsidomine on ischemic ST-segment depression in the exercise-ECG were determined in a randomized and double-blind acute study of 12 patients with confirmed coronary artery disease. With 2 mg molsidomine a significant reduction in the amount of ischemic ST-depression from 18.0 mm to 8.1 mm, 45% of the baseline-figure, resulted. With 6 mg molsidomine a diminuation of the ST-segment depression from 16.2 mm to 6 mm, approximately 40%, was noted. The significant antianginal effect of 2 mg molsidomine lasted at least 3 hours. After 5 hours an effect was seen only in some patients. 4 mg and 6 mg molsidomine still showed a significant reduction of ST-segment depression after 5 hours. A sufficient antianginal efect over 24 hours is only achieved with a 2-mg dose administered 5-6 times or with a 4-6 mg dose applied 4-5 times daily. The most marked fall in blood pressure was noticed after 6 mg molsidomine. On average, the systolic blood pressure fell 41 mm Hg (22%). Orthostatic reactions were not seen. The maximal dose-dependent plasma levels were 15.8 ng/ml, 30.1 ng/ml and 50.0 ng/ml. A definite, reliable clinical effect was seen in some cases from plasma levels above 2 ng/ml.

Angina Pectoris↗